#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cytokine release syndrome Alexander disease Ovarian cancer stage IV Primitive neuroectodermal tumour Hypersensitivity pneumonitis Autologous haematopoietic stem cell transplant Inflammatory myofibroblastic tumour High-grade B-cell lymphoma Myelodysplastic syndrome NTRK gene fusion overexpression Ewing's sarcoma Post transplant lymphoproliferative disorder Anti-myelin-associated glycoprotein antibodies positive Cholangitis sclerosing Polycythaemia vera More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Diagnostics Chondrosarcoma metastatic – Diagnostics Uterine leiomyosarcoma – Life with Disease Adrenocortical carcinoma – Treatment Angiosarcoma non-metastatic Short-bowel syndrome – Treatment Cytokine release syndrome – Treatment Myelodysplastic syndrome – Diagnostics Krabbe’s disease Marginal zone lymphoma refractory – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludarabine Phosphate Teriflunomide Cannabis Sativa Flower Munc-T3 Leriglitazone Gentamicin Evencaleucel Acetylcysteine Amide Maribavir ZINC CHLORIDE Vosoritide Sotatercept GSKVX000000034796 Prilocaine Acetylsalicylic Acid Ph. Eur. Vemurafenib Acetylcholine Chloride Propofol Vanglusagene Ensiparvovec 12 Grass Pollen Mixture More therapies…

    Learn about Your Condition

    Metabolic surgery Iron deficiency Osteosarcoma Perineal injury Osteochondrodysplasia Blood disorder Indolent systemic mastocytosis Breast cancer male Clinically isolated syndrome Radius fracture High-grade B-cell lymphoma Graft infection Open angle glaucoma Vulvovaginal candidiasis Depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cutaneous T-cell lymphoma

  • Topical delgocitinib safety study in patients with cutaneous T‑cell lymphoma (mycosis fungoides)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    Denmark

  • Study of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    Investigated Drugs:
    • Brentuximab Vedotin
    France

  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    • Diffuse large B-cell lymphoma
    • Cervix carcinoma
    Investigated Drugs:
    • Tolinapant Lactate
    Italy Spain

  • Study of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma recurrent
    • Cutaneous T-cell lymphoma
    Investigated Drugs:
    • Lacutamab
    Belgium France Germany Italy Poland Spain

  • Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Mogamulizumab
    Denmark France Germany Greece Italy Spain

  • Study on Tofacitinib for Patients with Mycosis Fungoides

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Tofacitinib
    Denmark
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!